Gene Ther Mol Biol
Vol 3, 423-435. August 1999.
The activation of the chicken lysozyme locus in
development is a cooperative process
Research Article
Matthias C. Huber1 and Constanze Bonifer1,2
1Institut fr Biologie III, Schnzlestr.1, 79104 Freiburg, Germany. 2Molecular
Medicine Unit, University of Leeds, St James University Hospital, Leeds LS9
7TF, UK
__________________________________________________________________________________________________
Corresponding author: Constanze Bonifer, Ph.D.
Molecular Medicine Unit, University of Leeds, St JamesŐs University Hospital,
Leeds LS9 7TF, UK. Tel: +44-113-2065676, Fax: +44-113-2444475; email:
c.bonifer@leeds.ac.uk
Received: 25 July 1998; accepted 16 October 1998
Summary
The
chicken lysozyme gene is a marker for the myelomonocytic lineage of the
hematopoietic system. In early experiments we demonstrated that correct
activation of the chicken lysozyme locus in macrophages of transgenic mice
requires the complete set of cis-regulatory elements. Different cis-elements
are activated at distinct developmental stages and their chromatin structure is
differentially remodelled. We have shown that the early onset of
transcriptional activation of the chicken lysozyme locus is entirely dependent
on enhancer elements which are structurally activated early in development
(-6.1 kb and -3.9 kb early enhancers). However, the structural reorganization
of the early enhancers requires the presence of promoter sequences. We
concluded from these experiments that the early enhancers and the promoter
cooperate in order to activate the lysozyme locus. Subsequently, we performed
experiments aimed at elucidating the cis-regulatory requirements of chromatin
rearrangement at the early enhancers. The -6.1 kb enhancer is well characterized
at the molecular level and all transcription factors contributing to its
activity in transfection studies are known. We have placed this element into a
new sequence context on the lysozyme locus by deleting extended flanking
regions and analyzed this construct in transgenic mice. Surprisingly, its
chromatin rearrangement ability as judged from DNaseI hypersensitive site
formation was impaired. We conclude from this experiment that the cooperation
of enhancer core and flanking sequences is necessary for enhancer activity. We
hypothesize that all sequences of a gene locus serve a purpose in the
developmental control of its activation.
I. Introduction
One of the key objectives in developmental
biology is to understand how the regulatory information from the genome is
translated into the controlled expression of different genes. The gradual
change in the activity of individual gene loci is the basis for the various
steps in the commitment of a differentiating cell towards the terminally
differentiated state. A large number of gene expression studies have been
performed to describe cellular differentiation processes. However, due to the
difficult nature of the experiments involved, the molecular details of cell
differentiation at the level of the genome still remain to be elucidated.
Eukaryotic genes are regulated by a number of different cis-regulatory elements
distributed over large distances. In addition it has been demonstrated that,
depending on the developmental stage, different combinations of transcription
factors can occupy the same cis-regulatory element (Roque et al., 1996; Gualdi
et al., 1996). It is known that different members of the same transcription
factor family can be differentially expressed in development. Thus, some
transcription factors will only transiently occupy cis-regulatory elements. At
present it is not clear, whether only one type or different factor family
members can occupy the same binding site within a larger protein complex at the
various developmental stages.
Another open question concerns the order of
transcription factor assembly. Many cis-regulatory elements are organized in
positioned nucleosomes (Richard -Foy and Hager, 1987; Straka and Hrz, 1991).
Since not all transcription factors are capable of binding when their recognition
sequences are organized in a nucleosomal core (Blomquist et al., 1996b; Taylor
et al., 1991; Pina et al., 1990) this, in turn, implies that a certain order of
factor complex assembly may be necessary for correct regulation. In addition,
factors capable of recruiting chromatin modifying enzyme like histone
acetylases might have to pave the way for other factors joining the
transcription complex later in the assembly process (reviewed in: Grunstein,
1997; Peterson and Tamkun, 1995).
Last, but not least, the role of sequences
flanking cis-regulatory elements has been elusive. The cores of cis-regulatory
elements are very often separated by long arrays of flanking DNA which on first
sight seem to serve no purpose. However, for genes whose role in different
species have been conserved, like the globin or the Hox gene clusters, we also
find a conservation of gene order and spacing, suggesting a regulatory role of
such sequences. It is therefore tempting to speculate that a eukaryotic gene
locus is not just a collection of cis-regulatory elements separated by ÒjunkÓ
DNA, but that there is more to it than that.
II. The lysozyme locus as a model for gene locus
activation
In order to answer these questions we have
been studying the molecular basis of transcriptional activation of the chicken
lysozyme locus in the myeloid lineage of the mammalian hematopoietic system.
The lysozyme locus is small (21 kb), thus facilitating the manipulation of
individual cis-regulatory elements within the context of an entire genomic
locus. Expression of the lysozyme gene is regulated by a combination of several
cis-regulatory elements located in the 5Ő-half of the locus. Three enhancers,
6.1kb-, 3.9 kb- and 2.7 kb upstream of the transcriptional start site as well
as a silencer element at -2.4 kb and a complex promoter (Baniahmad et al.,
1987; Grewal et al., 1992; Hecht et al., 1988; Theisen et al., 1986; Steiner et
al., 1987; Baniahmad et al., 1990; Luckow and Schutz, 1989; Sippel et al.,
1987a) have been identified. All active cis-regulatory elements colocalize with
DNaseI hypersensitive sites (DHSs) in chromatin (Fritton et al., 1984; Fritton
et al., 1987; Sippel et al., 1988; Huber et al., 1995; Sippel et al., 1996).
In order to be able to draw relevant
conclusions regarding the contribution of each cis-element to lysozyme gene
regulation, we first determined in transgenic mice which of several modified
constructs was specifically expressed in the right cell type (macrophages) and
was unaffected by chromosomal position effects. This holds true for the
complete chicken lysozyme locus carrying the full set of regulatory elements
(Bonifer et al., 1990). Deletion of one enhancer region abolishes position
independence of expression, indicating that for position independent transgene expression
the cooperative action of all cis-regulatory elements is necessary (Bonifer et
al., 1994b). Repression of gene expression by genomic position effects is
correlated with suppression of DHS formation and with an inefficient
reorganization of nucleosomes in the cis-regulatory regions (Huber et al.,
1994; Huber et al., 1996), indicating that active chromatin formation and
transcriptional activity are closely linked.
The structural activation of the lysozyme
locus takes place in several steps. Accordingly, the individual enhancer
elements of the lysozyme locus can be categorized into early or late enhancers.
The early enhancers at –6.1kb and –3.9kb and the promoter become
DNaseI hypersensitive at the myeloblast stage when the gene is also
transcriptionally activated. A low level of gene expression is observed. The
DHS at the silencer element is still present. The DHS at the late –2.7kb
enhancer appears only later in differentiation. Simultaneously, the -2.4kb
silencer disappears (Huber et al., 1995). Each cis-regulatory element shows an
distinct structural organization, with transcription factor binding sites
specifically arranged with respect to nucleosomes. Transcriptional activation
leads to a rearrangement of chromatin structure in an element-specific fashion
(Huber et al., 1996). The results of our structural studies suggest that the
correct alignment of transcription factor binding sites with respect to the
position of nucleosomes may be essential for their interaction and thus for
position independent expression.
III. The activation of the chicken lysozyme locus in
development requires the interaction of a subset of enhancer elements with the
promoter
Together with the promoter, each enhancer is
capable of activating the gene locus specifically in mature macrophages of
transgenic mice (Bonifer et al., 1994b; Jgle et al., 1997). However, the
temporal regulation of their activity is different, since the early enhancers
and the promoter are sufficient to activate the chicken lysozyme gene at the correct,
early developmental stage, whereas a deletion of the early -6.1kb enhancer
leads to a delay in gene activation, indicating that this element plays a
crucial role in the initial activation process (Jgle et al., 1997). The
presence of the -3.9 kb enhancer alone is insufficient for the early onset of
transcription.
We subsequently examined the role of the
promoter in lysozyme locus activation by analyzing a construct carrying the
complete lysozyme locus with an internal deletion of the promoter in transgenic
mice (Huber et al., 1997). Transcription from this construct was completely
abolished. However, the formation of a DHS at the -2.4 kb silencer element was
unaffected and in macrophages, the DHS at the -2.7 kb enhancer element was
formed. In contrast, DHS formation and chromatin remodelling at the early
–6.1 kb and -3.9 kb enhancers were abolished. Taken together our data
indicate that in the initial activation of the lysozyme locus the early
enhancers have to interact with the promoter.
How this interaction takes place and which
transcription factors are involved is at present unknown. However, since our
initial promoter deletion removed defined sequence elements from the complete
lysozyme locus without any further changes, we are now in the position to
replace defined sequence elements in the promoter and thus analyze
transcription factor interaction truly involved in gene locus activation.
IV. The –2.4 kb silencer and the -2.7 kb
enhancer are able to reorganize chromatin in the absence of a promoter
The -2.4kb silencer is inactive in mature,
lysozyme-expressing macrophages and is active in all other cell types analyzed.
It extends from -2310bp to -2410bp and carries a recognition sequence for
thyroid (TR) or retinoic acid (RXR) hormone receptors. The second identified
protein is the chicken homologue of factor CTCF (NeP1) (Khne et al., 1993;
Baniahmad et al., 1990; Arnold et al., 1996; Burcin et al., 1997). Our
transgenic mouse experiments now show that the silencer element is capable of
forming a DHS in any cell type also in the absence of a promoter. To our
surprise, in macrophages of such mice not only the -2.4kb DHS but also the
–2.7kb DHS was formed. This type of chromatin rearrangement is normally
correlated with maximal transcriptional activity of the lysozyme gene at late
macrophage differentiation stages.
We could show that the presence or absence of
the silencer element has no influence on the time course of activation of the
chicken lysozyme gene in developing macrophages (Jgle et al., 1997). It is
therefore possible that this element is repressing the activity of the
–2.7kb enhancer at early stages of macrophage differentiation. In both,
chicken and mouse macrophages, the increase in MNase- and DNaseI accessibility
at the enhancer parallels a decrease in accessibility at the silencer (Huber et
al., 1995; Huber et al., 1996; Sippel et al., 1988). Both elements are located
on adjacent positioned nucleosomes (Huber et al., 1996), whereby the factor
binding sites possibly face the same nucleosomal side. Such a spatial
arrangement suggests that silencer and enhancer are an integrated
cis-regulatory element, with factor binding at both sub-elements being mutually
exclusive. DNA bending, shown to be mediated by the active silencer complex on
this site (Arnold et al., 1996), may influence nucleosome phasing and thus the
spatial arrangement of the regulatory elements. The TR/RXR heterodimer is able
to bind its recognition sites within chromatin and to repress or activate
transcription in the absence or presence of thyroid hormone (TH) (Wong et al.,
1995).
However, since the chromatin reorganization in
the –2.4 kb/–2.7 kb region is cell differentiation dependent and
can be induced in cultured cells solely by induction with LPS (Huber et al.,
1995; Faust et al., 1997), we assume that it is independent of the presence of
a TR/RXR ligand and thus is at least partially driven by transcription factors
recognizing the enhancer element in a differentiation dependent fashion. We
could indeed demonstrate a LPS stimulated binding of members of the C/EBP
transcription factor family to the -2.7 kb enhancer (Faust N, Bonifer C, and
Sippel AE, submitted). Whether the formation of the DHS at the silencer element
is the structural prerequisite for the promoter-independent DHS formation of
the -2.7 kb enhancer or whether the factors binding to the enhancer are capable
of disrupting chromatin by themselves remains to be tested.
V. Results and Discussion
A. Enhancer promoter
interaction in lysozyme locus activation
Our earlier experiments have demonstrated the
existence of two different classes of cis-regulatory elements of the lysozyme
locus. The early enhancers at -6.1 kb and -3.9 kb need a promoter in order to
remodel chromatin, whereas the silencer element at -2.4 kb and the enhancer at
-2.7 kb do not (Figure 2). In turn,
our functional experiments showed that the correct timing of activation of the
lysozyme locus is dependent on the presence of the -6.1 kb enhancer. Figure 1 depicts our present model of
the various cell differentiation dependent regulatory states of the lysozyme
locus as deduced from our structural and functional experiments. In our
structural experiments we have employed retrovirally-transformed myeloid cell
lines representing various fixed differentiation states.
In differentiating primary cells we envisage
the structural reorganization of the complete lysozyme locus as a dynamic
process which involves the assembly and cooperative action of a large number of
transcription factors as well as chromatin modifying enzymes. In order to
understand the molecular details of this process we have to fully characterize
the transcription factor composition of each cis regulatory element. However,
here we encounter a problem: as with most other gene loci, most cis-regulatory
elements of the lysozyme locus have been defined and analyzed the classical
way, that is, by transient transfection assays as well as using in vitro and in
vivo DNA binding studies.
Figure 1. Model of the various steps in the
activation of the chicken lysozyme locus during macro-phage differentiation. (A) In lysozyme non-expressing cells we only find a DNaseI
hypersensitive chromatin site (DHS) at the silencer complex located -2.4 kb
upstream of the transcription start. (B)
In myeloblasts, which represent a cell type still capable of differentiating to
granulocytes and macrophages, DHS form at the promoter and at the early (-6.1
kb and -3.9 kb) enhancers. The presence of promoter sequences is essential for
DHS formation at the early enhancers.The early enhancers and the promoter are
sufficient to activate the lysozyme locus at the correct developmental stage. (C) In terminally differentiated and
activated macrophages the silencer complex is inactivated and the third
enhancer becomes active leading to a 20-fold increase in mRNA levels. The
position of the different cis-regulatory elements are indicated by black bars,
the coding region with the first two exons is depicted by striped boxes, and
the various cis-regulatory protein complexes are shown as differently patterned
shapes. The transcriptional activity of the lysozyme gene is indicated by
arrows of different sizes. Note that enhancer complexes are extending over
larger regions than the actual core sequences.
Figure
3 shows what we know about
the functional elements of the -6.1 kb enhancer and the promoter based on those
experiments. In our initial promoterless construct we had deleted sequences
from -1 bp to -830 bp. The promoter is a complex element, since it contains three
start sites for the RNA polymerase as well as a large collection of ubiquitous
and cell-specific transcription factor binding sites. Transcription factor
composition of the promoter in oviduct and macrophages is different, which is
reflected in a difference of DHS fine structure in the two tissues (Sippel et
al., 1988). In macrophages, an additional pair of DHS at -0.7 kb is formed.
However, promoter activity seems to entirely
reside on a fragment of approximately 250 bp in length; further upstream, an element
has been identified which exerts a negative effect on reporter gene expression
in transient transfection assays in macrophage cell lines (Steiner et al.,
1987). Consequently, only the proteins binding to this fragment have been
identified as being necessary for promoter function (Altschmied et al., 1989;
Dlle and Strtling, 1990) (Figure 3A).
Using a similar strategy, the functional elements of the -6.1 kb enhancer have
been assigned to reside on a sequence array of approximately 200 bp within a 596
bp BamHI - HindIII fragment encompassing the DHS at this position (Figure 3B). The minimal enhancer
fragment showing full enhancer activity in transient transfection assays was
assigned to an even smaller fragment (Grewal et al., 1992). In neither case was
it known whether the minimal elements, as defined by transient transfection
assays, are sufficient for their correct activation during ontogeny.
Figure 2. Chromatin structure of the wt and
promoter-less chicken lysozyme constructs in transgenic mice. Summary of chromatin
structure analyses of different constructs in different cell types of
transgenic mice as indicated on the left. At the top of each panel the 5«-
region of the chicken lysozyme constructs is depicted. The promoter deletion is
indicated as a black triangle. The main transcription start is indicated by a
horizontal arrow. Exons 1 and 2 are symbolized by grey boxes. Black arrows: DHS
displayed at wild type strength irrespective of the chromosomal location of the
transgene. Grey arrows: –2.4 kb- and –2.7 kb DHS displaying changes
in intensity according to the developmental stage of the cells. Striped arrows:
DHS forming with variable efficiency depending on the chromosomal position of
the transgene. (A): construct
carrying the full set of cis-regulatory elements; (B): construct carrying a promoter deletion.
B. Deletion of flanking sequences abolishes DHS formation at the -6.1 kb enhancer
Our original deletion of the -6.1 kb enhancer
which abolished the early onset of transcriptional upregulation had removed a
large fragment encompassing sequences from -5400 bp up to -8700 bp. We were now
interested to examine whether the 596 bp BamHI - HindIII fragment carried all
the information for its interaction with the promoter and, hence, for its
chromatin remodelling activity. We generated two transgenic mouse lines which
carried a deletion construct as described above but where the 596 bp fragment
carrying all the transcription factor binding sites found to be necessary for
enhancer activity had been reinserted, thus removing large flanking sequence
arrays and placing the -6.1 kb core enhancer element into a new sequence
context (Figure 5 B). The deletion
also removed a non-tissue specific weak DHS at -7.9 kb (see Figure 5 lane 15) of no apparent cis-regulatory function. As
expected, the deletion did not affect the tissue specificity of expression.
As in the transgenic mouse lines carrying the
complete locus, the lysozyme gene is expressed in a tissue specific fashion (Figure 4). Expression is only observed in hematopoietic tissues and, in
case of the BH 596.3 mouse line, also in the lung, a tissue which can contain
are large number of macrophage cells.
The wild type lysozyme locus construct
encompassing the complete chromatin domain is expressed also in the brain
(Bonifer et al., 1990; Bonifer et al., 1994b). Expression is truly ectopic, but
cell-specific and copy number-dependent, indicating that the trans-species
transgene is activated correctly in a brain cell type fortuitously containing
the correct transcription factor combination (Bonifer et al., 1994a).
Brain-specific expression is lost when the -6.1 kb enhancer is deleted (Bonifer
et al., 1994b). Interestingly, as opposed to the wild type locus, no ectopic
expression of the transgene in the brain is observed with the deletion
construct described here, indicating, that the -6.1 kb enhancer is not active
in the brain of these mice.
Structural studies confirmed these findings.
We isolated macrophages from transgenic mice carrying either the full set of
cis-regulatory elements (XS.0b mice) or the above described deletion construct
(BH596.1 and BH596.3 mice) and analyzed the DHS pattern in the -6.1 kb- and the
-3.9 kb enhancer region (Figure 4).
We also examined the nucleosomal pattern around the -2.4 kb silencer/ -2.7 kb
enhancer region using MNase digestion of nuclei of lysozyme non-expressing
embryonic fibroblasts and macrophages of XS.0b and BH 596 mice.
Figure 3. DNA - Protein interactions at the Promoter
(A) and at the early -6.1 kb enhancer (B). Summary of in vitro - and
in vivo DNA protein interactions at the promoter (A) and at the -6.1 kb
enhancer (B) of the chicken lysozyme locus. Transcription factor binding sites
as are indicated as differently patterned boxes, the nature of the presumed
transcription factor binding to this sequence is indicated above the sequence.
The data represent in (A) a compilation of the data from the following
references: (Altschmied et al., 1989; Dlle and Strtling, 1990; Grez et al.,
1981). LS defines linker scan mutations leading to a inhibition of promoter
activity as assayed by (Luckow and Schutz, 1989). The arrows in (B) indicate
the position of point mutations leading to a loss in enhancer activity as
described in (Grewal et al., 1992). The data in (B) represent a compilation of
the following references: (Grewal et al., 1992; Sippel et al., 1987a; Borgmeyer
et al., 1984; Sippel et al., 1987b).
Figure 4. Tissue specific expression pattern of BH596
mice. mRNA
expression analysis of BH596 mouse lines. Expression of the chicken lysozyme
gene in different tissues of two independently derived BH596 transgenic mouse
lines. Total RNA (20”g) was analyzed in an S1 protection assay with probes
specific for chicken lysozyme (upper
panel) or mouse §-actin (lower panel)
as described (Bonifer et al., 1990). Abbreviations below the lanes indicate the
investigated tissues / cell types. L: liver; H: heart; K: kidney; Lg: lung; S:
spleen; B: bone marrow; T: thymus; M: peritoneal macrophage. Lane (-): no RNA;
HD11: RNA prepared from HD11 cells stimulated with LPS. The numbers at the
right indicate the positions of the three major start sites at the lysozyme
promoter (Grez et al., 1981).
Embryonic fibroblasts show a regular MNase
pattern indicative of a phased nucleosome over both elements which is perturbed
after the activation of the -2.7 kb enhancer in macrophages (Figure 6). This pattern is identical in
both mouse lines indicating that the deletion does not affect the nucleosomal
organization of these elements. In addition, no difference between the mouse
lines was observed with respect to the formation of the DHS at the -3.9 kb
enhancer. We have already shown that the presence or absence of the -6.1 kb
enhancer has no effect on the formation of an active promoter structure (Huber
et al., 1996). However, the deletion of flanking sequences strongly affected
DHS formation at the -6.1 kb enhancer. In contrast to the mice carrying the
complete lysozyme locus which show a strong DHS at the position of the -6.1 kb
enhancer, no DHS is formed at the position of reinserted BamHI - Hind III fragment. This indicates that flanking
regions are required for DHS formation at the -6.1 kb enhancer. The DNA region
required to stabilize a functional enhancer complex at -6.1 kb is obviously
much larger than previously anticipated.
At present we do not fully understand the
molecular basis of our finding. Several explanations are possible which most
likely are not mutually exclusive. Firstly, we know that in its inactive state
the -6.1 kb enhancer is organized in a phased nucleosome which is remodelled by
enhancer activation (Huber et al., 1996). It is therefore possible that this
preset chromatin structure is disturbed in case of the enhancer deletion, which
would in turn lead to a disturbance of enhancer activation. One of the crucial
transcription factors involved in enhancer activity is nuclear factor I (NFI)
which by itself in unable to bind to DNA organized in a nucleosome irrespective
of nucleosome positioning (Pina et al., 1990; Blomquist et al., 1996a). In
vivo, this factor requires assistance to be able to bind to its recognition
sequence in chromatin (Perlmann and Wrange, 1988; Truss et al., 1995). In our
case, this assistance might be prohibited by a change in chromatin
architecture.
Secondly, it is possible that earlier in vivo
and in vitro DNA-binding studies have failed to detect low affinity binding
sites for factors binding to flanking sequences recruited by the factors
binding to the enhancer cores. In vivo a large complex might be formed which is
too fragile to be reconstituted in vitro using conventional extract preparation
and assembly technology.
Thirdly, the constitutive hypersensitive site
at -7.9 kb may be involved in stabilizing the -6.1 kb enhancer complex.
Figure 5. The deletion of flanking sequences around
the core of the -6.1 kb enhancer abolishes DNAseI hypersensitive site formation
at the -6.1 kb enhancer but not at the -3.9 kb enhancer. (A) DHS mapping with macrophages of mouse line XS.0b (lanes 2 - 5)
which expresse the lysozyme gene in a position independent manner and mouse
lines BH596.3 and BH596.1 (lanes 5 - 9 and lanes 10 - 13, respectively). Lane
15: Nuclei prepared from chicken HD11 promacrophage cells. M: size marker.
Genomic DNA was prepared, restricted with SphI, transferred to a nylon membrane
and hybridized with probe DS indicated at the map at the right. The map on the
right indicates the position of SphI restriction sites and the position of the
-6.1 kb enhancer DHS in the wt- (grey circle) and the deletion construct (white
circle). Note that in the BH596 construct one SphI site is deleted. The
position of the -3.9 kb DHS is indicated by a grey oval bar. (B) Map of the wild type locus (upper
panel) and the BH596 deletion construct (lower panel). The coding region is
indicated by the white box with the exon sequences drawn as black bars and the
transcriptional start site as horizontal arrow. The positions of the DHSs
mapped in macrophages are shown as vertical arrows, constitutive DHSs are
indicated as smaller arrows. The position of the upstream enhancer region and
the medial enhancer region are indicated as stippled boxes. The nature of the
cis regulatory elements and their position relative to the transcriptional
start site are shown in the lowest panel. E: enhancer element; S: silencer
element; P: promoter elements. The position and nature of the transcription
factors binding to the 596 bp BamHI - HindIII fragment are indicated below the
line.
Figure 6. The deletion of upstream sequences does
not affect nucleosomal remodelling at the -2.7 kb enhancer. MNase analysis of the
–2.4 kb silencer/–2.7 kb enhancer region in the BH596.3 mouse line.
Lanes 1 - 6: MNase digestion pattern of nuclei prepared from mouse line XS.0b
(restricted with SphI - SacI); lanes 1-3: analysis of MNase digestion pattern
in the chromatin of transgenic mouse macrophages; lanes 4 - 6: embryonic
fibroblasts. Lane 7: DHS pattern of HD11 nuclei in the analyzed region
(symbolized by small grey circles). Lanes 8 - 15: MNase analysis of nuclei
prepared from macrophages (lanes 8 - 11) or embryonic fibroblasts (lane 12 -
15) of mouse line BH596.3. The probe used for indirect end-labelling (SpS) is
indicated by a stippled box on the map depicted at the right. Prominent MNase
cleavage sites are indicated by arrows, cleavage sites only observed in
macrophages are indicated by striped arrows. M: Size markers.
Finally, it is possible that the deletion of
sequences upstream of the -6.1 kb have brought this element too close to the
boundaries of the DNaseI sensitive domain. It has been demonstrated that these
regions have insulator properties (Stief et al., 1989). Recently, it could be
shown that they contain high affinity binding sites for the chicken homologue
of the methyl-binding-protein MeCP2, which acts as a transcriptional repressor
(Weitzel et al., 1997). The repressor activity of this protein can be explained
by the finding that it is capable of recruiting a histone deacetylase. It is
therefore tempting to speculate that the DNaseI-resistant chromatin of the
domain borders has spread into the newly inserted -6.1 kb enhancer sequences
thus rendering this element inactive. Taken together, these explanations
suggest that with our present technology in identifying cis-regulatory elements
we are missing out essential regulatory features of eukaryotic gene loci which
are crucial for locus activation in a developmentally-regulated system. It also
demonstrates that it is important to analyse the composition of cis-regulatory
elements in their natural sequence context.
C. All sequences of a
eukaryotic locus are part of a functional unit
The activation of the chicken lysozyme locus
during cell differentiation is a stepwise process. Our analysis of the
developmental activation of the lysozyme locus has demonstrated a definitive
requirement for all cis-regulatory elements of the gene locus to cooperate. The
chicken lysozyme locus harbors no single element with dominant chromatin
opening function. Although an element exists which is able to stably reconfigure
chromatin in the absence of promoter elements, it acts later in cell
differentiation and its chromatin reorganizing capacity is limited to its site.
The differentiation-dependent reorganization and activation of the lysozyme
locus is mediated by the interplay of separate cis-regulatory elements with
distinct abilities to generate or maintain transcription competent chromatin
structures. Our results support the concept that all essential cis-regulatory
elements (enhancer and promoter elements) have to be integrated into one
functional entity to perform locus activation in transgenic mice.
In the study described here, we demonstrate in
addition that the characterization of the early -6.1 kb enhancer by transient
transfection assays has been incomplete and that not only a promoter but also
enhancer flanking sequences are required for the developmentally-controlled
chromatin remodelling activity of this element. Several laboratories have
independently detected a cis-regulatory role for enhancer core flanking
regions. The results of our experiments are reminiscent of a study in which the
activity of one of the major control elements of the human adenosine deaminase
(ADA) gene was examined. This control region is located in the first intron and
is essential for the correct activation of the ADA locus in transgenic mice
(Aronow et al., 1995). It has also been demonstrated in this system that a core
enhancer region is insufficient for the activation of the enhancer in
transgenic mice. Flanking regions are required which have no enhancer activity
on their own.
In another study the role of sequences outside
the cores of the DNaseI hypersensitive sites of the b-globin LCR has been examined (Jackson et al., 1996).
Also here, a cis-regulatory role of these regions could be established. It was
found that a strong synergism in transcriptional stimulation was observed when
sequences outside the cores were present and the natural spacing between the
hypersensitive sites was preserved. A sequence comparison between b-globin LCRs of different mammals indeed revealed a
high level of sequence conservation of certain core flanking sequences
(Slightom et al., 1997), indicating an important role of these sequences in LCR
function. At present it is unknown which type of information is encoded in
enhancer core flanking regions. The fact that individual sequence motifs are
evolutionary conserved, however, points to the presence of important
transcription factor binding sites. It may also be possible that structural
information is present which, at the moment, we are unable to identify.
What we can detect with our classical
techniques like DNaseI hypersensitive site mapping, in vitro DNA binding
studies and transient transfection studies may be nothing but the Òtip of the
icebergÓ in terms of clusters of high affinity transcription factor binding
sites. We might be unable to detect scattered single or low affinity factor
binding sites. Taken together it is obvious that gene locus activation is a
cooperative process. What emerges from our work and the above described
experiments is the concept that this cooperative process may involve all
sequences of a eukaryotic gene locus, some of which span hundreds of kilobases.
The elucidation of the type of information encoded in these sequences and the
way this information is translated into the enormous complexities of
developmentally-controlled gene expression will be a major challenge for
developmental biologists in the next years.
Acknowledgements
The authors thank Gudrun Krger for expert
technical assistance and Dr. Louise Coletta, Molecular Medicine Unit, for
critically reading the manuscript. This work was supported by a grant from the
Deutsche Forschungsgemeinschaft to C.B
VI. Materials and Methods
A.
Construction of pIIIilysBH596
The pIIIilysBH596
plasmid was constructed by cloning the BamHI - HindIII fragment
carrying the -6.1 kb enhancer (Theisen et al., 1986) in sense orientation into
the Asp718 site (at -5.4 kb upstream of the trasncription start) of plasmid
PIIIilysdXK (Bonifer et al., 1994b) which carried a deletion of a fragment
between -5.4 kb and -8.7 kb.
B.
Transgenic mice, cell culture and mRNA expression analysis
Production of the
BH596 transgenic mouse lines by pronuclear injection of DNA was essentially
performed as described in Hogan et al. (1994). First-generation heterozygous
mice from the founders BH959.1 and BH593.3 were examined for intact integration
and construct integrity by Southern blotting. Copy-numbers were calculated from
Southern blots as described by Bonifer et al. (1990) and phosphorimager
analysis. BH 596.1 mice carried 2 copies and BH596.3 mice carried 18 copies of
the lysozyme locus. Expression and chromatin analysis were performed with
homozygous progeny. Transgenic mouse lines carrying the XS construct (Bonifer
et al., 1994b) were kept as homozygous lines in our mouse colony. Primary
macrophages were prepared from the peritoneal cavity of transgenic mice as
described (Bonifer et al., 1990). For each transgenic mouse line, cells from 12
- 20 mice were taken in culture in standard Iscove«s medium supplemented with
10% fetal calf serum (FCS) and 10% L-cell conditioned medium for 16 hours.
Embryonic fibroblasts were prepared from mouse embryos 12 days after
fertilization as described earlier (Huber et al., 1994). HD11 cells were grown
in standard Iscove«s medium containing 8% FCS and 2% chicken serum. Preparation
of mRNA and the S1 protection analyses were performed as described in (Bonifer
et al., 1990).
C.
Nuclei preparation
Nuclei were prepared
by homogenizing cultured cells on ice with a Dounce homogenizer in buffer 1
(0.15mM spermine, 0.5mM spermidine, 15mM Tris-HCl pH 7.5, 60mM KCl, 15mM NaCl,
2mM EDTA, 0.5mM EGTA, 500mM Sucrose, 1mM PMSF) followed by centrifugation for 5
min at 1000g at 4ĄC. Nuclei were washed once in buffer 2 (buffer 1 + 0.5%
Triton X-100), followed by a wash in buffer 3 (buffer 1 but with 350mM instead
of 500mM Sucrose). After this wash nuclei were centrifuged for 5 min at 600g at
4ĄC.
D.
DNaseI and MNase digestion analysis
Aliquots of 2 x 107
to 1 x 108 nuclei in 100-200”l of buffer 3 were centrifuged for 5
min at 600g and 4ĄC and thereafter resuspended in buffer 4 (0.15mM spermine,
0.5mM spermidine, 15mM Tris-HCl pH 7.5, 60mM KCl, 15mM NaCl, 0.2mM ETDA, 0.2mM
EGTA). DNaseI digestions were performed in 500”l buffer 4. To 2x107
nuclei 0, 4, 10, 20 and 40 Units/ml DNaseI (Pharmacia) were added. HD11 nuclei
were digested with 24 Units/ml DNaseI. Digestion was started by adding 4mM MgCl2
and 2mM CaCl2. Incubations (15 min, 4ĄC) were stopped by adding 10”l
0.5M EDTA. MNase1 digestions were performed in 200”l buffer 4. To 2x107
nuclei 0, 15, 80 Units MNase (Pharmacia) were added. Digestion was started by
adding 10”l CaCl2 (100mM) and stopped after incubation (5 min, 25ĄC)
by the addition of 10”l 0.5M EDTA.
Digestion of naked
genomic DNA with MNase was performed in 150”l 10mM Tris-HCl pH7.5 with 0.2 -
6.4 Units/ml MNase. Incubations (15 min, 25ĄC) were started by adding 15”l CaCl2
(10mM) and stopped with 15”l 50mM EDTA. After DNaseI or MNase digestion nuclei
were lysed in 500”l Tris-HCl pH 8.0, 2mM ETDA, 0.2% SDS, 0.5mg/ml Proteinase K
and incubated overnight at 37ĄC. RNase A (0.2mg/ml) was then added and after a
further incubation at 37ĄC for 1h the DNA was precipitated three times with
ethanol. Digested DNA was cleaved with restriction enzymes for indirect
end-labelling analysis and 7 - 30”g of fragmented DNA were loaded on 3mm thick
vertical 1% agarose gels (DNaseI analysis) or 10mm thick vertical 1.5% agarose
gels (MNase analysis). The DNA was transferred to Biodyne B membrane and the
filter was hybridized with an appropriate probe (a SphI-SpeI fragment from
-3163 to -2906bp) for indirect endlabelling.
References
Altschmied, J.,
Mller, M., Baniahmad, S., Steiner, S., and Renkawitz, R. (1989). Cooperative interaction of chicken lysozyme enhancer
sub-domains partially overlapping with a steroid receptor binding site. Nucleic Acids Res. 17, 4975-4991.
Arnold, R., Burcin,
M., Kaiser, R., Muller, M., and Renkawitz, R. (1996). DNA bending by the silencer protein NeP1 is modulated by TR
and RXR. Nucleic Acids Res. 24,
2640-2647.
Aronow, B., Ebert,
C.A., Valerius, M.T., Potter, S.S., Wiginton, D.A., Witte, D.P., and Hutton,
J.J. (1995). Dissecting a locus
control region: facilitation of enhancer function by extended enhancer-flanking
sequences. Mol. Cell. Biol. 15,
1123-1135.
Baniahmad, A.,
Mller, M., Steiner, C., and Renkawitz, R. (1987). Activity of two different silencer elements of the chicken
lysozyme gene can be compensated by enhancer elements. EMBO J. 6, 2297-2303.
Baniahmad, A.,
Mller, M., Steiner, C., and Renkawitz, R. (1990). Modular structure of chicken lysozyme silencer: involvement
of an unusual thyroid receptor binding site. Cell 61, 729-740.
Blomquist, P., Li,
Q., and Wrange, O. (1996a). The
affinity of nuclear factor I for its DNA site is drastically reduced by
nucleosome organization irrespective of its rotational or translational
position. J. Biol. Chem. 271,
153-159.
Blomquist, P., Li,
Q., and Wrange,
. (1996b). The
affinity of nuclear factor I for its DNA site is drastically reduced by
nucleosome organisation irrespective of its rotational or translational
position. J. Biol. Chem. 271,
153-159.
Bonifer, C., Vidal,
M., Grosveld, F., and Sippel, A.E. (1990).
Tissue specific and position independent expression of the complete gene domain
for chicken lysozyme in transgenic mice. EMBO
J. 9, 2843-2848.
Bonifer, C., Bosch,
F., Faust, N., Schuhmann, A., and Sippel, A.E. (1994a). Evolution of gene regulation as revealed by differential
regulation of the chicken lysozyme transgene and the endogenous mouse lysozyme
gene in mouse macrophages. Eur. J.
Biochem. 226, 227-235.
Bonifer, C., Yannoutsos,
N., Krger, G., Grosveld, F., and Sippel, A.E. (1994b). Dissection of the locus control function located on the
chicken lysozyme gene domain in transgenic mice. Nucleic Acids Res. 22, 4202-4210.
Borgmeyer, U.,
Nowock, J., and Sippel, A.E. (1984).
The TGGCA-binding protein: A eucaryotic nuclear protein recognizing a
symmetrical sequence in double stranded linear DNA. Nucleic Acids Res. 12, 4295-4311.
Burcin, M., Arnold,
R., Lutz, M., Kaiser, B., Runge, D., Lottspech, F., Filipova, G.N., Lobanenkov,
V.V., and Renkawitz, R. (1997).
Negative protein 1, which is required for the function of the chicken lysozyme
gene silencer in conjunction with hormone receptors is identical to the
multivalent zinc finger repressor CTCF. Mol.
Cell. Biol. 17, 1281-1288.
Dlle, A. and
Strtling, W.H. (1990). Genomic
footprinting of proteins interacting with the chicken lysozyme promoter. Gene 95, 187-193.
Faust, N., Huber,
M.C., Sippel, A.E., and Bonifer, C. (1997).
Different macrophage populations develop from embryonic/fetal and adult
hematopoietic tissues. Exp. Hematology
25, 432-444.
Fritton, H.P.,
Igo-Kemenes, T., Nowock, J., Strech-Jurk, U., Theisen, M., and Sippel, A.E. (1984). Alternative sets of DNase
I-hypersensitive sites characterize the various functional states of the
chicken lysozyme gene. Nature 311,
163-165.
Fritton, H.P.,
Igo-Kemenes, T., Nowock, J., Strech-Jurk, U., Theisen, M., and Sippel, A.E. (1987). DNase I-hypersensitive sites in
the chromatin structure of the lysozyme gene in steroid hormone target and
non-target cells. Biol. Chem.
Hoppe-Seyler 368, 111-119.
Grewal, T., Theisen,
M., Borgmeyer, U., Grussenmeyer, T., Rupp, R.A.W., Stief, A., Qian, F., Hecht,
A., and Sippel, A.E. (1992). The
-6.1-kilobase chicken lysozyme enhancer is a multifactorial complex containing
several cell-type-specific elements. Mol.
Cell. Biol. 12, 2339-2350.
Grez, M., Land, H.,
Giesecke, K., Schtz, G., Jung, A., and Sippel, A.E. (1981). Multiple mRNAs are generated from the chicken lysozyme gene.
Cell 25, 743-752.
Grunstein, M. (1997). Histone acetylation in chromatin
structure and transcription. Nature
389, 349-352.
Gualdi, R., Bossard,
P., Zheng, M., Hamada, Y., Coleman, J.R., and Zaret, K.S. (1996). Hepatic specification of the gut endoderm in vitro: cell
signaling and transcriptional control. Genes
Dev 10, 1670-1682.
Hecht, A.,
Berkenstam, A., Strmstedt, P.-E., Gustafsson, J.-A., and Sippel, A.E. (1988). A progesterone responsive
element maps to the far upstream steroid dependent DNase hypersensitive site of
the chicken lysozyme gene. EMBO J.
7, 2063-2073.
Hogan, B.,
Beddington, R., Constantini, F., and Lacy, E. (1994). Manipulating the mouse embryo - A Laboratory Manual (CSHL
Press).
Huber, M.C., Bosch,
F., Sippel, A.E., and Bonifer, C. (1994).
Chromosomal position effects in chicken lysozyme gene transgenic mice are
correlated with suppression of DNaseI hypersensitive site formation. Nucleic Acids Res. 22, 4195-4201.
Huber, M.C., Graf,
T., Sippel, A.E., and Bonifer, C. (1995).
Dynamic changes in the chromatin of the chicken lysozyme gene domain during
differentiation of multipotent progenitors to macrophages. DNA Cell. Biol 14, 397-402.
Huber, M.C., Jgle,
U., Krger, C., and Bonifer, C. (1997).
The developmental activation of the chicken lysozyme locus in transgenic mice
requires the interaction of a subset of enhancer elements with the promoter. Nucleic Acids Res. 25, 2992-3000.
Huber, M.C., Krger,
G., and Bonifer, C. (1996). Genomic
position effects lead to an inefficient reorganization of nucleosomes in the
5`-regulatory region of the chicken lysozyme locus in transgenic mice. Nucleic Acids Res. 24, 1443-1453.
Jackson, J.D.,
Petrykowskaja, H., Philipsen, S., Miller, W., and Hardison, R. (1996). Role of DNA sequences outside
the cores of DNase hypersensitive sites (HSs) in function of the §-globin locus
control region. J. Biol. Chem. 271,
11871-11876.
Jgle, U., Mller,
A.M., Kohler, H., and Bonifer, C. (1997).
Role of positive and negative cis-regulatory elements regions in the regulation
of transcriptional activation of the lysozyme locus in developing macrophages
of transgenic mice. J. Biol. Chem.
272, 5871-5879.
Khne, A.C.,
Banaihmad, A., and Renkawitz, R. (1993).
A ubiquitous transcription factor synergizes with v-erbA in transcriptional
silencing. J. Mol. Biol. 232, 747-755.
Luckow, B. and
Schtz, G. (1989). Cell-type
specificity of regulatory elements identified by linker scanning mutagenesis in
the promoter of the chicken lysozyme gene. Nucleic
Acids Res. 17, 8451-8462.
Perlmann, T. and
Wrange,
. (1988). Specific glucocorticoid
receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7, 3073-3079.
Peterson, C.L. and
Tamkun, J.W. (1995). The SWI-SNF
complex: a chromatin remodeling machine? TIBS
20, 143-156.
Pina, B.,
Brggemeier, U., and Beato, M. (1990).
Nucleosome positioning modulates accessibility of regulatory proteins to the
mouse mamary tumor virus promoter. Cell
60, 719-731.
Richard -Foy, H. and
Hager, G.L. (1987).
Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV
promotor. EMBO J. 6, 2321-2328.
Roque, M.C., Smith,
P.A., and Blasquez, V.C. (1996). A
developmentally modulated chromatin structure at the mouse immunoglobilin 3«
enhancer. Mol. Cell. Biol. 16,
3138-3155.
Sippel, A.E.,
Borgmeyer, U., Pschel, A.W., Rupp, R.A.W., Stief, A., Strech-Jurk, U., and
Theisen, M. (1987a). Multiple
nonhistone protein-DNA complexes in chromatin regulate the cell- and
stage-specific activity of a eukaryotic gene. In Results and Problems in Cell
Differentiation 14. Structure and
Function of Eukaryotic Chromosomes. W. Hennig, ed. (Heidelberg: Springer
Verlag), pp. 255-269.
Sippel, A.E.,
Borgmeyer, U., Pschel, A.W., Rupp, R.A.W., Stief, A., Strech-Jurk, U., and
Theisen, M. (1987b). Multiple
nonhistone protein-DNA complexes in chromatin regulate the cell- and
stage-specific activity of an eucaryotic gene. In Results and Problems in Cell Differentiation. W. Hennig, ed.
(Berlin Heidelberg: Springer-Verlag), pp. 255-269.
Sippel, A.E.,
Saueressig, H., Huber, M.C., Hoefer, H.C., Stief, A., Borgmeyer, U., and
Bonifer, C. (1996). Identification
of cis-acting elements as DNaseI hypersensitive sites in lysozyme chromatin. Methods in Enzymology 274, 233-246.
Sippel, A.E.,
Theisen, M., Borgmeyer, U., Strech-Jurk, U., Rupp, R.A.W., Pschel, A.W.,
Mller, A., Hecht, A., Stief, A., and Grussenmeyer, T. (1988). Regulatory function and molecular structure of
DNaseI-hypersensitive elements in the chromatin domain of a gene. In The Architecture of Eukaryotic Genes.
G. Kahl, ed. (Weinheim: Verlagsgesellschaft Chemie(VHC)), pp. 355-369.
Slightom, J.L., Bock,
J.H., Tagle, D.A., Gumucio, D.L., Goodman, M., Stojanovic, N., Jackson, J.,
Miller, W., and Hardison, R. (1997).
The complete sequence of the Galago and Rabbit §-globin locus control regions:
extended sequence and functional conservation outside the cores of DNaseI
hypersensitive sites. Genomics 39,
90-94.
Steiner, C., Mller,
M., Baniahmad, A., and Renkawitz, R. (1987).
Lysozyme gene activity in chicken macrophages is controlled by positive and
negative regulatory elements. Nucleic
Acids Res. 15, 4163-4178.
Stief, A., Winter,
D.M., Strtling, W.H., and Sippel, A.E. (1989).
A nuclear attachment element mediates elevated and position independent gene
activity. Nature 341, 343-345.
Straka, C. and Hrz,
W. (1991). A functional role for
nucleosomes in the repression of a yeast promoter. EMBO J 14, 1727-1736.
Taylor, I.C.A.,
Workman, J.L., Schuetz, T.J., and Kingston, R.E. (1991). Facilitated binding of GAL4 and heat shock factor to
nucleosomal templates: differential function of DNA-binding domains. Genes Dev. 5, 1285-1298.
Theisen, M., Stief,
A., and Sippel, A.E. (1986). The
lysozyme enhancer: cell-specific activation of the chicken lysozyme gene by a
far-upstream element. EMBO J. 5,
719-724.
Truss, M., Bartsch,
J., Schelbert, A., Hache, R.J.G., and Beato, M. (1995). Hormone induces binding of receptors and transcription
factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J. 14, 1737-1751.
Weitzel, J.M.,
Buhrmester, H., and Strtling, W.H. (1997).
Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding
protein MeCP2. Mol. Cell. Biol. 17,
5656-5666.
Wong, J., Shi, Y.-B.,
and Wolffe, A.P. (1995). A role for
nucleosome assembly in both silencing and activation of the Xenopus TR§A gene
by the thyroid hormone receptor. Genes
Dev. 9, 2696-2711.